These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 27942212)

  • 1. Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation.
    Pangeni R; Choi SW; Jeon OC; Byun Y; Park JW
    Int J Nanomedicine; 2016; 11():6379-6399. PubMed ID: 27942212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of Oxaliplatin-Deoxycholic Acid Derivative Nanocomplexes and In Vivo Evaluation of Their Oral Absorption and Tumor Growth Suppression.
    Jeon OC; Byun Y; Park JW
    J Nanosci Nanotechnol; 2016 Feb; 16(2):2061-4. PubMed ID: 27433728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect.
    Pangeni R; Choi JU; Panthi VK; Byun Y; Park JW
    Int J Nanomedicine; 2018; 13():3329-3351. PubMed ID: 29922055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsion.
    Choi JU; Maharjan R; Pangeni R; Jha SK; Lee NK; Kweon S; Lee HK; Chang KY; Choi YK; Park JW; Byun Y
    J Control Release; 2020 Jun; 322():13-30. PubMed ID: 32169534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal transport mechanism and in vivo anticancer efficacy of a solid oral formulation incorporating an ion-pairing complex of pemetrexed with deoxycholic acid derivative.
    Pangeni R; Jha SK; Maharjan R; Choi JU; Chang KY; Choi YK; Byun Y; Park JW
    Int J Nanomedicine; 2019; 14():6339-6356. PubMed ID: 31496690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvements in the Oral Absorption and Anticancer Efficacy of an Oxaliplatin-Loaded Solid Formulation: Pharmacokinetic Properties in Rats and Nonhuman Primates and the Effects of Oral Metronomic Dosing on Colorectal Cancer.
    Pangeni R; Subedi L; Jha SK; Kweon S; Kang SH; Chang KY; Choi JU; Byun Y; Park JW
    Int J Nanomedicine; 2020; 15():7719-7743. PubMed ID: 33116497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, Characterization, and In Vivo Evaluation of an Oral Multiple Nanoemulsive System for Co-Delivery of Pemetrexed and Quercetin.
    Pangeni R; Panthi VK; Yoon IS; Park JW
    Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30213140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced oral bioavailability of an etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative-lipid complex.
    Jha SK; Han HS; Subedi L; Pangeni R; Chung JY; Kweon S; Choi JU; Byun Y; Kim YH; Park JW
    Drug Deliv; 2020 Dec; 27(1):1501-1513. PubMed ID: 33107339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of skin cancer using low HLB surfactant nanoemulsion of 5-fluorouracil: a preliminary study.
    Shakeel F; Haq N; Al-Dhfyan A; Alanazi FK; Alsarra IA
    Drug Deliv; 2015; 22(4):573-80. PubMed ID: 24350612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats.
    Gorain B; Choudhury H; Kundu A; Sarkar L; Karmakar S; Jaisankar P; Pal TK
    Colloids Surf B Biointerfaces; 2014 Mar; 115():286-94. PubMed ID: 24388859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy.
    Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA
    Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paeonol nanoemulsion for enhanced oral bioavailability: optimization and mechanism.
    Chen S; Zhang J; Wu L; Wu H; Dai M
    Nanomedicine (Lond); 2018 Feb; 13(3):269-282. PubMed ID: 29338580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequences.
    Boisdron-Celle M; Craipeau C; Brienza S; Delva R; Guérin-Meyer V; Cvitkovic E; Gamelin E
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):235-43. PubMed ID: 11935216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionic complex of risedronate with positively charged deoxycholic acid derivative: evaluation of physicochemical properties and enhancement of intestinal absorption in rats.
    Park JW; Byun Y
    Arch Pharm Res; 2014 Dec; 37(12):1560-9. PubMed ID: 24254935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Oral Methioninase (o-rMETase) Combined With Oxaliplatinum Plus 5-Fluorouracil Improves Survival of Mice With Massive Colon-Cancer Peritoneal Carcinomatosis.
    Kim MJ; Han Q; Bouvet M; Hoffman RM; Park JH
    Anticancer Res; 2023 Jan; 43(1):19-24. PubMed ID: 36585181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancer.
    Shen Q; Wang Y; Zhang Y
    Int J Nanomedicine; 2011; 6():1237-43. PubMed ID: 21753875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced bioavailability and antihypertensive activity of nisoldipine loaded nanoemulsion: optimization, cytotoxicity and uptake across Caco-2 cell line, pharmacokinetic and pharmacodynamic studies.
    Mundada VP; Patel MH; Mundada PK; Sawant KK
    Drug Dev Ind Pharm; 2020 Mar; 46(3):376-387. PubMed ID: 32031412
    [No Abstract]   [Full Text] [Related]  

  • 18. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
    Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
    Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
    Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M
    Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model.
    Zhu G; Zhao M; Han Q; Tan Y; Sun YU; Bouvet M; Singh SR; Ye J; Hoffman RM
    Anticancer Res; 2019 Nov; 39(11):5999-6005. PubMed ID: 31704825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.